Indian Journal of Urology Users online:3349  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size


 
  Table of Contents 
CASE REPORT
Year : 2011  |  Volume : 27  |  Issue : 1  |  Page : 137-139
 

Primary malignancy of seminal vesicle: A rare entity


Department of Surgical Oncology, Govt Royapettah Hospital, Chennai, India

Date of Web Publication29-Mar-2011

Correspondence Address:
Rajaraman Ramamurthy
"Rama Swathi". Old No.11, New No. 25, 7th main road, Raja Annamalaipuram, Chennai - 600 0028, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0970-1591.78417

Rights and Permissions

 
   Abstract 

We report a rare case of seminal vesicle malignancy (primitive neuro ectodermal tumor) in a 40-year-old male patient. He was treated with enbloc resection of the tumor and ureteric reimplantation. In view of the rarity of this entity, management of these tumors should be individualized.


Keywords: Seminal vesicle malignancy, primitive neuro ectodermal tumor, primary tumors of genitourinary tract


How to cite this article:
Ramamurthy R, Periasamy S, Mettupalayam V. Primary malignancy of seminal vesicle: A rare entity. Indian J Urol 2011;27:137-9

How to cite this URL:
Ramamurthy R, Periasamy S, Mettupalayam V. Primary malignancy of seminal vesicle: A rare entity. Indian J Urol [serial online] 2011 [cited 2019 Oct 19];27:137-9. Available from: http://www.indianjurol.com/text.asp?2011/27/1/137/78417



   Introduction Top


Primary malignant tumors in seminal vesicle are rarely encountered in clinical practice. Secondary spread is quite common either due to disseminated disease or by contiguous spread from adjacent organ, most commonly from prostate. [1] There is paucity of data regarding management protocols and most of the time the treatment is individualized. We report a case of seminal vesicle malignancy managed by us.


   Case Report Top


A 40-year-old male patient reported to us with a history of hematospermia and pain during ejaculation of four months duration. He gave a history of unsuccessful treatment for infertility in the past having married for 15 years. Physical examination revealed a mass in the region of right seminal vesicle about 3 × 4 cm in size. Further imaging studies with MRI [Figure 1], [Figure 2] and CT scan showed a right seminal vesicle mass with right hydronephrosis. Cystoscopy showed a bulge in the region of right vesico ureteric junction without any mucosal lesion. Exploratory laparotomy finding was a right seminal vesicle mass 3 ×4 cm with right hydronephrosis [Figure 3]. The opposite seminal vesicle and prostate were normal. The tumor was focally adherent to the bladder wall and encasing the right distal ureter. There were a few enlarged right iliac nodes. Frozen section analysis of a biopsy of the mass confirmed malignancy but the pathologist could not characterize the lesion further. We proceeded to resect the right seminal vesicle enbloc along with distal 3 cms of right ureter and part of the bladder with veisico ureteric junction [Figure 4]. Right ureter was reimplanted into the dome of the bladder. His postoperative recovery was uneventful and has been disease-free for the past four months
Figure 1: MRI of the patient showing the rt seminal vesicle sandwiched between bladder and rectum

Click here to view
Figure 2: MRI showing the tumor's relationship to the ureter

Click here to view
Figure 3: Intraoperative picture showing the tumor

Click here to view
Figure 4: Enbloc removal of the rt seminal vesicle along with partial cystectomy

Click here to view


Histopathological examination of the specimen showed the right seminal vesicle to be completely replaced by the tumor and focally involving the bladder wall but mucosa was free. Although the right ureter was encased, it was not infiltrated by the tumor and all nodes were free of tumor. Histology was small round cells and further immunohistochemical analysis revealed it to be a primitive neuro ectodermal tumor (PNET). Cytokeratin, Vimentin, CD 99, S 100 were positive and LCA, Desmin, HMB45, Synaptophysin were negative.IHC study for PSA and PSAP were also negative. He was offered further adjuvant chemotherapy.


   Disscusion Top


Seminal vesicle is most commonly involved by contiguous spread from adjacent organs and the most common being the prostate. It is also involved by disseminated malignancy. But primary malignant tumors of seminal vesicle are extremely rare and only 100 such cases have been reported in the literature. [2] Only two cases of PNET of seminal vesicle have been reported in the literature. [3],[4] It is important to differentiate between primary and secondary spread as the former is a localized disease with possibility of cure while the later is usually an advanced disease with dismal prognosis.

Strict diagnostic criteria are required to classify the tumor as primary seminal vesicle malignancy as secondary involvement is more common. Most common organs from where malignancies spread to seminal vesicle are prostate, bladder and rectum. About 12% of prostate malignancy involves seminal vesicle. Bladder and rectal malignancies involve seminal vesicle only when the primary is locally advanced.

Seminal vesicle malignancies are classified as adenocarcinoma, mesenchymal tumors and mixed epithelial tumors. Adenocarcinoma is the most common primary malignant tumor of the seminal vesicle with the tumour confined to the seminal vesicle without prostatic involvement. Immunohistochemical studies should be negative for both PSA and prostate specific acid phosphatise. [5] Mixed epithelial tumors [6] should have no normal seminal vesicle inside the tumor, without invasion of the prostate and immunohistochemical studies should be negative for both PSA and prostate specific acid phosphatase.

In our patient, the entire seminal vesicle was replaced by the tumor and prostate was uninvolved. Although tumor was adherent to the bladder at one place both bladder mucosa and mucosa of ureter were free of tumor. Management of this entity should be individualized as there is no well established protocol. Lower urinary tract symptoms especially hematospermia point to possible seminal vesicle pathology. It is evaluated further by imaging studies either CT or MRI. Seminal vesicle pathology is imaged as a retro vesical mass in the anatomical region of seminal vesicle. This is usually followed by a transrectal ultrasound (TRUS) which establishes the diagnosis. If TRUS is inconclusive or nondiagnostic and the seminal vesicle malignancy is operable on imaging one may proceed with exploratory laparotomy. Operable primary seminal vesicle adenocarcinomas are treated with radical surgery - cystoprostosemino-vesiculolectomy with bilateral pelvic lymphadenectomy. Long term survival data are not available. No definite recommendations are available for adjuvant therapy, which must be individualized.

PNET belong to Ewing family of tumors, which are characterized by small round blue cells and associated chromosomal abnormality of balanced tranlocation in chromosome 22. Although they occur in any age group they are more common in pediatric age and in young adults. Multimodality treatment which includes surgery, radiotherapy and chemotherapy are used in the management but treatment protocols are yet to be standardized. Generally, for localized resectable disease surgery is preferred and for advanced or unresectable disease radiation is used to achieve local control. Chemotherapy is added either as an adjuvant or delivered as neoadjuvant before surgery. The most active chemotherapeutic agents are vincristine, actinomycin D, cyclophosphamide and doxorubicin. Ifosamide and etoposide may be added. The optimal combination of chemotherapeutic drugs and sequencing of multimodality treatment are still debated and should be individualized.


   Conclusion Top


Primary seminal vesicle malignancy is a rare entity and should be diagnosed only after applying strict diagnostic criteria. There is paucity of data in evaluating and managing these tumors. Management of these tumors should be individualized. Surgery is the best option for localized operable lesions although long term data is not available.

 
   References Top

1.Turek PJ. Seminal vesicle and Ejaculatory duct surgery. In: Graham SD, editor. Glenn's urologic surgery. 6 th ed. Philadelphia: Lippincott: Williams and Wilkins; 2004. p. 439-49.  Back to cited text no. 1
    
2.Bostwick DG. Seminal Vesicles. In: Bostwick DG. Urologic surgical pathology. 2 nd ed. China: Mosby Elsevier; 2008. p. 582-90.  Back to cited text no. 2
    
3.Lawrentschuk N, Appu S, Chao I, Chan Y, Rogerson J, Davis ID. Peripheral primitive neuroectodermal tumor arising from the seminal vesicle. Urol Int 2008;80:212-5.  Back to cited text no. 3
    
4.de Paula AA, Maltez AR, Mota ED. Small round blue cell tumor of seminal vesicle in a young patient. Int Braz J Urol 2006;32:566-9.  Back to cited text no. 4
    
5.Tarjan M, Ottlecz I, Tot T. Primary adenocarcinoma of the seminal vesicle. Indian J Urol 2009;25:143-5.  Back to cited text no. 5
[PUBMED]  Medknow Journal  
6.Khan MS, Zaheer LU, Ahmed K, Cahill D, Horsfield C, Rottenberg G, et al. Low-grade phyllodes tumor of the seminal vesicle treated with laparoscopic excision. Nat Clin Pract Urol 2007;4:395-400.  Back to cited text no. 6
    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]



 

Top
Print this article  Email this article
 

    

 
   Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Article in PDF (1,535 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
    Introduction
    Case Report
    Disscusion
    Conclusion
    References
    Article Figures

 Article Access Statistics
    Viewed4175    
    Printed105    
    Emailed1    
    PDF Downloaded73    
    Comments [Add]    

Recommend this journal

HEALTHWARE INDIA